North America Viral Vaccines Cdmo Market Size & Outlook
Related Markets
North America viral vaccines cdmo market highlights
- The North America viral vaccines cdmo market generated a revenue of USD 855.0 million in 2024.
- The market is expected to grow at a CAGR of 14.5% from 2025 to 2033.
- In terms of segment, attenuated vaccine was the largest revenue generating type in 2024.
- Subunit Vaccines is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2033.
North America data book summary
| Market revenue in 2024 | USD 855.0 million |
| Market revenue in 2033 | USD 2,715.7 million |
| Growth rate | 14.5% (CAGR from 2025 to 2033) |
| Largest segment | Attenuated vaccine |
| Fastest growing segment | Subunit Vaccines |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Attenuated Vaccine, Inactivated Vaccine, DNA Vaccines, Subunit Vaccines |
| Key market players worldwide | Lonza Group Ltd, Catalent Pharma Solutions, Thermo Fisher Scientific, Inc., Alcami, Samsung BioLogics, FUJIFILM Diosynth Biotechnologies, WuXi Biologics., Recipharm AB, HALIX, Batavia Biosciences |
Other key industry trends
- In terms of revenue, North America region accounted for 38.3% of the global viral vaccines cdmo market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,561.9 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Vaccines CDMO Market Scope
Viral Vaccines CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| FUJIFILM Diosynth Biotechnologies | View profile | - | - | - |
| Recipharm AB | View profile | - | - | - |
| WuXi Biologics. | View profile | - | - | - |
| Thermo Fisher Scientific, Inc. | View profile | - | - | - |
| Catalent Pharma Solutions | View profile | 5001-10000 | Somerset, New Jersey, United States, North America | http://www.catalent.com |
| HALIX | View profile | 11-50 | Leiden, Zuid-Holland, The Netherlands, Europe | https://www.halix.nl |
| Batavia Biosciences | View profile | 101-250 | Leiden, Zuid-Holland, The Netherlands, Europe | http://www.bataviabiosciences.com/ |
| Alcami | View profile | 501-1000 | Wilmington, North Carolina, United States, North America | http://www.alcaminow.com |
| Samsung BioLogics | View profile | 1001-5000 | Incheon, Inch'on-jikhalsi, South Korea, Asia | https://www.samsungbiologics.com/ |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
North America viral vaccines cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vaccines cdmo market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 39.42% in 2024. Horizon Databook has segmented the North America viral vaccines cdmo market based on attenuated vaccine, inactivated vaccine, dna vaccines, subunit vaccines covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America viral vaccines cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America viral vaccines cdmo market databook
-
Our clientele includes a mix of viral vaccines cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America viral vaccines cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into North America viral vaccines cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America viral vaccines cdmo market size, by country, 2021-2033 (US$M)
North America Viral Vaccines CDMO Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
